Indication
Prurigo nodularis
Prurigo nodularis is a chronic, inflammatory neuroimmune dermatologic disorder that most commonly affects middle-aged to older adults and individuals with atopic diathesis or chronic pruritic systemic conditions. Read more about Prurigo nodularis
4 drugs 2 manufacturers
Drugs that treat it
Common Prurigo nodularis therapies.
DUPIXENT PEN (dupilumab)
DUPIXENT SYRINGE (dupilumab)
NEMLUVIO (nemolizumab-ilto)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrurigo nodularis is a chronic, inflammatory neuroimmune dermatologic disorder that most commonly affects middle-aged to older adults and individuals with atopic diathesis or chronic pruritic systemic conditions.
It is clinically characterized by the development of multiple, firm, intensely pruritic, hyperkeratotic papules and nodules that typically exhibit a symmetric distribution over the extensor surfaces of the limbs and the trunk.
Pathophysiologically, the disease is sustained by a dysregulated itch-scratch cycle involving complex neuroimmune crosstalk, characterized by cutaneous neural hyperplasia, local release of neuropeptides, and type 2 helper T-cell-mediated cytokine signaling that drives recalcitrant neurogenic inflammation and epidermal thickening.
- nih.gov
Prurigo nodularis is a chronic, inflammatory neuroimmune dermatologic disorder that most commonly affects middle-aged to older adults and individuals with atopic diathesis or chronic pruritic systemic conditions It is clinically characterized by the development of multiple, firm, intensely pruritic, hyperkeratotic papules and nodules that typically exhibit a symmetric distribution over the extensor surfaces of the limbs and the trunk Pathophysiologically, the disease is sustained by a dysregulat...
- clevelandclinic.org
Prurigo nodularis is a chronic, inflammatory neuroimmune dermatologic disorder that most commonly affects middle-aged to older adults and individuals with atopic diathesis or chronic pruritic systemic conditions
- apexclinicalresearchcenter.com
Prurigo nodularis is a chronic, inflammatory neuroimmune dermatologic disorder that most commonly affects middle-aged to older adults and individuals with atopic diathesis or chronic pruritic systemic conditions Pathophysiologically, the disease is sustained by a dysregulated itch-scratch cycle involving complex neuroimmune crosstalk, characterized by cutaneous neural hyperplasia, local release of neuropeptides, and type 2 helper T-cell-mediated cytokine signaling that drives recalcitrant neurog...
- nih.gov
It is clinically characterized by the development of multiple, firm, intensely pruritic, hyperkeratotic papules and nodules that typically exhibit a symmetric distribution over the extensor surfaces of the limbs and the trunk
- nemluvio.com
Pathophysiologically, the disease is sustained by a dysregulated itch-scratch cycle involving complex neuroimmune crosstalk, characterized by cutaneous neural hyperplasia, local release of neuropeptides, and type 2 helper T-cell-mediated cytokine signaling that drives recalcitrant neurogenic inflammation and epidermal thickening
Personalize your experience
Follow Prurigo nodularis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.